Fig. 4From: Immunogenicity and safety of RAZI recombinant spike protein vaccine (RCP) as a booster dose after priming with BBIBP-CorV: a parallel two groups, randomized, double blind trialLocal and systemic adverse reactions were reported within seven days after injection of RCP and BBIBP-CorV. Adverse reactions are graded according to the FDA toxicity grading scales. A Local adverse reactions. B Systemic adverse reactionsBack to article page